Vanguard Personalized Indexing Management LLC Sells 3,766 Shares of Intuitive Surgical, Inc. $ISRG

Vanguard Personalized Indexing Management LLC lessened its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 6.6% during the third quarter, HoldingsChannel reports. The institutional investor owned 53,711 shares of the medical equipment provider’s stock after selling 3,766 shares during the period. Vanguard Personalized Indexing Management LLC’s holdings in Intuitive Surgical were worth $24,029,000 at the end of the most recent quarter.

Other hedge funds also recently made changes to their positions in the company. Tufton Capital Management lifted its stake in shares of Intuitive Surgical by 28.4% in the third quarter. Tufton Capital Management now owns 1,288 shares of the medical equipment provider’s stock worth $576,000 after acquiring an additional 285 shares during the period. Avantax Planning Partners Inc. increased its position in Intuitive Surgical by 29.3% during the 3rd quarter. Avantax Planning Partners Inc. now owns 1,868 shares of the medical equipment provider’s stock valued at $835,000 after purchasing an additional 423 shares during the period. Sovran Advisors LLC raised its holdings in Intuitive Surgical by 2.8% during the 3rd quarter. Sovran Advisors LLC now owns 1,488 shares of the medical equipment provider’s stock worth $665,000 after purchasing an additional 41 shares during the last quarter. Patron Partners LLC lifted its position in shares of Intuitive Surgical by 7.6% in the 3rd quarter. Patron Partners LLC now owns 2,404 shares of the medical equipment provider’s stock worth $1,075,000 after purchasing an additional 170 shares during the period. Finally, WealthShield Partners LLC boosted its stake in shares of Intuitive Surgical by 5.8% in the 3rd quarter. WealthShield Partners LLC now owns 4,401 shares of the medical equipment provider’s stock valued at $1,968,000 after purchasing an additional 240 shares during the last quarter. 83.64% of the stock is currently owned by institutional investors.

Insider Buying and Selling

In related news, EVP Myriam Curet sold 7,562 shares of the business’s stock in a transaction dated Tuesday, October 28th. The shares were sold at an average price of $548.43, for a total value of $4,147,227.66. Following the transaction, the executive vice president directly owned 353 shares of the company’s stock, valued at approximately $193,595.79. The trade was a 95.54% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, EVP Henry L. Charlton sold 13,731 shares of the stock in a transaction dated Wednesday, November 12th. The shares were sold at an average price of $580.00, for a total transaction of $7,963,980.00. Following the transaction, the executive vice president owned 3,056 shares of the company’s stock, valued at approximately $1,772,480. The trade was a 81.80% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold a total of 55,714 shares of company stock valued at $31,617,799 over the last quarter. Corporate insiders own 0.70% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities analysts recently weighed in on ISRG shares. BTIG Research reissued a “buy” rating and set a $616.00 target price on shares of Intuitive Surgical in a research note on Friday. Royal Bank Of Canada boosted their price objective on Intuitive Surgical from $625.00 to $650.00 and gave the company an “outperform” rating in a research note on Wednesday, December 17th. Leerink Partners upped their target price on Intuitive Surgical from $593.00 to $600.00 and gave the company an “outperform” rating in a research report on Wednesday, October 22nd. Evercore ISI lowered their target price on Intuitive Surgical from $580.00 to $550.00 and set an “in-line” rating for the company in a report on Friday. Finally, The Goldman Sachs Group restated a “buy” rating and set a $714.00 price target on shares of Intuitive Surgical in a report on Friday, January 9th. One investment analyst has rated the stock with a Strong Buy rating, fifteen have issued a Buy rating, nine have given a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $618.70.

Intuitive Surgical Trading Down 0.3%

Shares of ISRG stock opened at $523.99 on Monday. The firm has a fifty day simple moving average of $562.32 and a two-hundred day simple moving average of $511.56. Intuitive Surgical, Inc. has a 12 month low of $425.00 and a 12 month high of $609.08. The firm has a market capitalization of $187.84 billion, a PE ratio of 66.41, a price-to-earnings-growth ratio of 4.26 and a beta of 1.67.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings results on Thursday, January 22nd. The medical equipment provider reported $2.53 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.27 by $0.26. The business had revenue of $2.87 billion during the quarter, compared to the consensus estimate of $2.72 billion. Intuitive Surgical had a return on equity of 15.06% and a net margin of 28.38%.The company’s quarterly revenue was up 18.8% on a year-over-year basis. During the same quarter in the previous year, the business earned $2.21 EPS. On average, equities analysts predict that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

About Intuitive Surgical

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.